Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Pancreatic Neoplasms HELP
Based on 30,763 articles published since 2009
|||| 45 

These are the 30763 published articles about Pancreatic Neoplasms that originated from Worldwide during 2009-2019.
 
+ Citations + Abstracts
Pages: 1 · 2 · 3 · 4 · 5 · 6 · 7 · 8 · 9 · 10 · 11 · 12 · 13 · 14 · 15 · 16 · 17 · 18 · 19 · 20
101 Editorial Barriers to Surgical Resection of Pancreatic Adenocarcinoma. 2019

Latchana, Nicholas / Coburn, Natalie. ·Department of Surgery, University of Toronto, Toronto, ON, Canada. · Division of General Surgery, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, ON, Canada. · Department of Surgery, University of Toronto, Toronto, ON, Canada. natalie.coburn@sunnybrook.ca. · Division of General Surgery, Odette Cancer Centre - Sunnybrook Health Sciences Centre, Toronto, ON, Canada. natalie.coburn@sunnybrook.ca. · Sunnybrook Research Institute, Toronto, ON, Canada. natalie.coburn@sunnybrook.ca. · Institute of Clinical Evaluative Sciences, Toronto, ON, Canada. natalie.coburn@sunnybrook.ca. ·Ann Surg Oncol · Pubmed #30406483.

ABSTRACT:

102 Editorial A valuable guideline of radioactive 2018

Hertzanu, Yancu / Ye, Xin. ·Department of Radiology, Ben Gurion University, Israel. · Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong University, Ji'nan, China. ·J Cancer Res Ther · Pubmed #30589022.

ABSTRACT:

103 Editorial A Glimmer of Hope for Pancreatic Cancer. 2018

Kindler, Hedy L. ·From the Section of Hematology-Oncology, University of Chicago Medicine, Chicago. ·N Engl J Med · Pubmed #30575492.

ABSTRACT: -- No abstract --

104 Editorial Pancreatic cancer: challenges and opportunities. 2018

Zhu, Huiyun / Li, Tuo / Du, Yiqi / Li, Min. ·Department of Gastroenterology, Changhai Hospital, Shanghai, 200433, China. · Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA. · Department of Endocrinology, Changzheng Hospital, Shanghai, 200003, China. · Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, USA. Min-Li@ouhsc.edu. ·BMC Med · Pubmed #30463539.

ABSTRACT: Pancreatic cancer is the fourth leading cause of cancer-related death in the United States, with increasing incidence. The mortality rate of pancreatic cancer is rising rapidly, and is projected to be the second most common of all malignant tumors by 2030. However, the diagnosis and therapy of pancreatic cancer remain a formidable challenge. Recently, enormous efforts have been made to develop several new methods for the early diagnosis and treatment of pancreatic cancer. We briefly introduce the most groundbreaking advances in pancreatic cancer diagnosis and clinical treatment strategies over the past 15 years, including surgery, chemotherapy, endoscopic therapy, immunotherapy and personalized medicine. The signaling pathways that are altered in the progression of pancreatic cancer, which may be used as therapeutic targets, are also discussed.

105 Editorial Impact of preoperative EUS-guided FNA for pancreatic cancer on overall and cancer-free survival: Is the jury still out? 2018

El Hajj, Ihab I / Al-Haddad, Mohammad. ·Division of Gastroenterology and Hepatology, Section of Interventional Endoscopy, Indiana University School of Medicine, Indianapolis, Indiana, USA. ·Gastrointest Endosc · Pubmed #30449404.

ABSTRACT: -- No abstract --

106 Editorial KRAS mutations in ctDNA: a promising new biomarker in advanced pancreatic cancer. 2018

Montagut, C / Vidal, J / Visa, L. ·Department of Medical Oncology, Hospital del Mar-IMIM, CIBERONC, Barcelona, Spain. ·Ann Oncol · Pubmed #30423018.

ABSTRACT: -- No abstract --

107 Editorial Refining Classification of Pancreatic Cancer Subtypes to Improve Clinical Care. 2018

Aguirre, Andrew J. ·Department of Medical Oncology, Dana Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts and Broad Institute of MIT and Harvard, Cambridge, Massachusetts. Electronic address: Andrew_Aguirre@dfci.harvard.edu. ·Gastroenterology · Pubmed #30419209.

ABSTRACT: -- No abstract --

108 Editorial Long-Term Follow-Up of Low-Risk Branch Duct IPMNs of the Pancreas: Watch for Main Pancreatic Duct Dilatation, and for How Long? 2018

Muniraj, Thiruvengadam / Aslanian, Harry R. ·Section of Digestive Disease, Yale School of Medicine, New Haven, CT, USA. thiruvengadam.muniraj@yale.edu. · Section of Digestive Disease, Yale School of Medicine, New Haven, CT, USA. ·Clin Transl Gastroenterol · Pubmed #30353003.

ABSTRACT:

109 Editorial Novel and emerging innate immune therapeutic targets for pancreatic cancer. 2018

Wang, Liang / Shureiqi, Imad / Stroehlein, John R / Wei, Daoyan. ·a Department of Gastroenterology, Hepatology and Nutrition , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. · b Department of Gastrointestinal Medical Oncology , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. · c Department of Patient Affairs , The University of Texas MD Anderson Cancer Center , Houston , TX , USA. ·Expert Opin Ther Targets · Pubmed #30332892.

ABSTRACT: -- No abstract --

110 Editorial The Agenda for Accelerating Pancreatic Research. 2018

Andersen, Dana K / Forsmark, Christopher E / Pandol, Stephen J. ·Division of Gastroenterology, Department of Medicine, University of Florida Health Sciences Center, Gainesville, FL. · Division of Digestive and Liver Diseases, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA. ·Pancreas · Pubmed #30325854.

ABSTRACT: -- No abstract --

111 Editorial Intercepting Pancreatic Cancer: Our Dream Team's Resolve to Stop Pancreatic Cancer. 2018

Goggins, Michael G / Lippman, Scott M / Constantinou, Pamela E / Jacks, Tyler / Petersen, Gloria M / Syngal, Sapna / Maitra, Anirban. ·Division of Hematology/Oncology, Department of Medicine, Moores Center for Personalized Cancer Therapy, University of California, San Diego, La Jolla, CA. · Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, TX. · Department of Health Sciences Research, Mayo Clinic College of Medicine, Rochester, MN. ·Pancreas · Pubmed #30325853.

ABSTRACT: -- No abstract --

112 Editorial Focus on pancreatic cancer. 2018

Silvestris, Nicola / Falconi, Massimo. ·Medical Oncology Unit and Scientific Directorate, Cancer Institute "Giovanni Paolo II", Bari, Italy. Electronic address: n.silvestris@oncologico.bari.it. · Pancreatic Surgery Unit, Pancreas Translational and Research Institute, Scientific Institute, San Raffaele Hospital, University Vita e Salute, Milan, Italy. ·Dig Liver Dis · Pubmed #30301604.

ABSTRACT: -- No abstract --

113 Editorial Features of Immune Cells and the Tumor-Associated Stroma Tango as Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma. 2018

Sonohara, Fuminori / Goel, Ajay. ·Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas. · Center for Gastrointestinal Research, Center for Translational Genomics and Oncology, Baylor Scott & White Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas. Electronic address: Ajay.Goel@BSWHealth.org. ·Gastroenterology · Pubmed #30300611.

ABSTRACT: -- No abstract --

114 Editorial The use of radiofrequency ablation in pancreatic cancer in the midst of the dawn of immuno-oncology. 2018

Reccia, Isabella / Kumar, Jayant / Habib, Nagy / Sodergren, Mikael. ·Department of Surgery & Cancer, Hammersmith Campus, Imperial College London, Du Cane Road, London, W12 0NN, UK. isabella.reccia@gmail.com. · Department of Surgery & Cancer, Hammersmith Campus, Imperial College London, Du Cane Road, London, W12 0NN, UK. · Department of Surgery & Cancer, Hammersmith Campus, Imperial College London, Du Cane Road, London, W12 0NN, UK. m.sodergren@imperial.ac.uk. ·Med Oncol · Pubmed #30284649.

ABSTRACT: Despite significant improvement in treatment, the prognosis of pancreatic ductal adenocarcinoma remains poor as the biology of the tumour affects survival even when a radical resection has been performed. Pancreatic cancer remains resistant to currently available chemotherapeutic options. Recently, immunotherapy has achieved significant results in certain types of cancer. However, for pancreatic cancer, results were not initially encouraging as pancreatic cancer microenvironment is highly immunosuppressive. Radiofrequency ablation is currently used as treatment option especially for liver cancer with significant results. However, in pancreatic cancer, the use of radiofrequency ablation is relatively new. Radiofrequency ablation has been identified as a promising mechanism to induce antigen-presenting cell infiltration and enhance systemic antitumour T-cell immune response and tumour regression. In this short communication, we briefly review the role of radiofrequency ablation in pancreatic cancer and explore the idea that the combination of radiofrequency ablation with immunotherapy could represent a novel and promising treatment.

115 Editorial CT Assessment of Pancreatic Cancer: What Are the Gaps in Predicting Surgical Outcomes? 2018

Fowler, Kathryn J. ·From the Department of Diagnostic Radiology, University of California San Diego, 200 W Arbor Dr, Room 8756, San Diego, CA 92103. ·Radiology · Pubmed #30251932.

ABSTRACT: -- No abstract --

116 Editorial Factors Predictive of Malignancy Potency in Pure Branch Duct Intraductal Papillary Mucinous Neoplasm of the Pancreas without Mural Nodules. 2018

Lee, Tae Hoon. ·Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University School of Medicine, Cheonan, Korea. ·Gut Liver · Pubmed #30205669.

ABSTRACT: -- No abstract --

117 Editorial Harnessing Analytic Morphomics for Early Detection of Pancreatic Cancer. 2018

Petrov, Maxim S. ·From the Department of Surgery, University of Auckland, Auckland, New Zealand. ·Pancreas · Pubmed #30199485.

ABSTRACT: -- No abstract --

118 Editorial Time to think: Selecting patients who may benefit from synchronous resection of primary pancreatic cancer and liver metastases. 2018

Shi, Si / Yu, Xian-Jun. ·Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China. ·World J Gastroenterol · Pubmed #30197474.

ABSTRACT: Pancreatic cancer remains a lethal disease and is associated with poor prognosis, particularly for patients with distant metastasis at diagnosis. Recently, Oweira reported a retrospective study that included 13233 metastatic pancreatic cancer patients from the Surveillance, Epidemiology and End Results database. They demonstrated that pancreatic cancer patients with isolated liver metastases had worse outcomes than patients with isolated lung metastases or distant nodal metastases. At present, the standard treatment for metastatic pancreatic cancer is chemotherapy. However, improvement in the safety of pancreatic surgery has led to the consideration of more aggressive surgical approaches. Schneitler reported two cases of hepatic metastatic pancreatic cancer in which negative margin (R0) resection and long survival were achieved after effective preoperative chemotherapy. In general, these two studies indicate that although pancreatic cancer patients with liver metastasis have a poor prognosis, surgical approaches may prolong survival for a few of these patients. A strategy to select hepatic metastatic pancreatic cancer patients who may benefit from surgical intervention is urgently needed.

119 Editorial Dynamic Behavior of Ca 19-9 and Pancreatic Cancer Recurrence: Enough Data to Drive Salvage Therapy? 2018

Malleo, Giuseppe. ·Unit of General and Pancreatic Surgery, Department of Surgery and Oncology, University of Verona Hospital Trust, G.B. Rossi Hospital, Verona, Italy. giuseppe.malleo@aovr.veneto.it. ·Ann Surg Oncol · Pubmed #30128901.

ABSTRACT: -- No abstract --

120 Editorial Gastroenterological Cancer and Immunotherapy. 2018

Wang, Xiaoping / Yang, Yixin Eric / Jia, Lintao / Chen, Qi. ·Department of Pathology, Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, China. · School of Natural Sciences, College of Natural, Applied and Health Sciences, Kean University, Union, NJ, USA. · Department of Molecular Biology, Fourth Military Medical University, Xi'an, Shaanxi, China. · Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, KS, USA. ·Can J Gastroenterol Hepatol · Pubmed #30073155.

ABSTRACT: -- No abstract --

121 Editorial Guidelines for the diagnosis and treatment of pancreatic adenocarcinoma (2018 edition): A standardized procedure recommended in China. 2018

Wang, Wen-Quan / Liu, Liang / Ni, Quan-Xing / Yu, Xian-Jun. ·Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Shanghai Pancreatic Cancer Institute; Pancreatic Cancer Institute, Fudan University, Shanghai 200032, China; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China. ·Hepatobiliary Pancreat Dis Int · Pubmed #30054169.

ABSTRACT: -- No abstract --

122 Editorial Cyst wall brushing. Exploring the limits of cytology. 2018

Martínez Moreno, Belén / Aparicio Tormo, José Ramón. ·Hospital Universitario del Vinalopó. · Hospital General Universitario de Alicante, España. ·Rev Esp Enferm Dig · Pubmed #30032626.

ABSTRACT: With the increasingly widespread use of imaging techniques pancreatic cystic lesions (PCLs) are now commonly identified. Their prevalence among the symptom-free population ranges from 2.4% to 13.5%. However, a recent study by our group revealed PCLs in up to 21.5% of patients undergoing endoscopic ultrasound (EUS) for non-pancreas conditions, an incidence that increases with age. Identifying PCLs in an otherwise asymptomatic population has become a significant clinical issue.

123 Editorial Distal pancreatectomy in the community setting: Application of the Donabedian principles. 2018

Greene, Frederick L. ·Cancer Data Services, Levine Cancer Institute, Charlotte, NC, USA; University of North Carolina School of Medicine, USA. Electronic address: rick_greene@med.unc.edu. ·Surg Oncol · Pubmed #30017174.

ABSTRACT: -- No abstract --

124 Editorial Pancreatic Cancer Chemoprevention: Challenges and Opportunities. 2018

Mohammed, Altaf / Rao, Chinthalapally V. ·Chemopreventive Agent Development Research Group (CADRG) Division of Cancer Prevention National Cancer Institute Rockville, MD 20850, United States. · Center for Cancer Prevention and Drug Development (CCPDD) Stephenson Cancer Center, Medical Oncology University of Oklahoma Health Sciences Center Oklahoma City, OK 73104, United States. ·Curr Med Chem · Pubmed #30014794.

ABSTRACT: -- No abstract --

125 Editorial Sweet Predictions Speak Volumes for Early Detection of Pancreatic Cancer. 2018

Soreide, Kjetil. ·Gastrointestinal Translational Research Unit, Stavanger University Hospital, Stavanger, Norway and Clinical Surgery, University of Edinburgh and Royal Infirmary of Edinburgh, Edinburgh, UK and Clinical Medicine, University of Bergen, Bergen, Norway and Department of Gastrointestinal Surgery, Stavanger University Hospital, Stavanger, Norway. Electronic address: ksoreide@mac.com. ·Gastroenterology · Pubmed #29966611.

ABSTRACT: -- No abstract --

Back · Next